Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2005
10/20/2005US20050233004 Composition of Chinese drugs having neuro-protecting activity
10/20/2005US20050232982 drug layer, support layer insoluble in water comprising ethyl cellulose and hydroxypropyl methylcellulose, backing on support layer, wherein drug layer consists of fentanyl or salt as active ingredient, methyl vinyl ether-maleic anhydride copolymer as adhesive, hydroxypropylcellulose; easily removed
10/20/2005US20050232913 Short chain neurotoxin from sea snake-lapemis hardwickii and genes encoding the neurotoxin
10/20/2005US20050232908 Novel use of the extract of processed ginseng and saponin isolated therefrom
10/20/2005US20050232870 Method of treatment of dopamine-related dysfunction
10/20/2005DE20221397U1 Transdermal-Pflaster zum Verabreichen von Fentanyl Transdermal patch for administering fentanyl
10/20/2005CA2563513A1 Remedy for neurodegenerative diseases
10/20/2005CA2563123A1 Selective antagonists of a2a adenosine receptors
10/20/2005CA2563033A1 Novel gamma secretase inhibitors
10/20/2005CA2562371A1 Diarylamine derivatives as calcium channel blockers
10/20/2005CA2562231A1 Active substance combination of a carbinol compound and an opioid
10/20/2005CA2562223A1 Treatment of autoimmune disorders of the skin with a goat serum obtained from a goat challenged with hiv immunogen
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/20/2005CA2561945A1 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
10/20/2005CA2561791A1 Non-imidazole heterocyclic compounds
10/20/2005CA2561627A1 Oxadiazolone derivatives as ppar delta agonists
10/20/2005CA2561616A1 Sleep-improving composition
10/20/2005CA2561532A1 Methods for detecting substances which bind to the amyloid precursor protein or beta amyloid fragments, and binding compounds
10/20/2005CA2561280A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
10/20/2005CA2561221A1 Rna interference modulators of hedgehog signaling and uses thereof
10/20/2005CA2561162A1 Method of treating schizophrenia and/or glucoregulatory abnormalities
10/20/2005CA2561159A1 Use of peroxisome proliferator activated receptor delta agonists for the treatment of ms and other demyelinating diseases
10/20/2005CA2559740A1 Thiadiazolidinones as gsk-3 inhibitors
10/20/2005CA2557850A1 Methods of treatment using eszopiclone
10/20/2005CA2555859A1 Compounds with atypical antipsychotic activity
10/19/2005EP1586642A2 Tumor supressor genes, proteins encoded thereby and use of said genes and proteins
10/19/2005EP1586584A1 Modulators of beta-amyloid peptide aggregation comprising D-amino acids
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1586556A2 Compounds to treat Alzheimer's disease
10/19/2005EP1586329A1 Botulinum toxin pharmaceutical compositions
10/19/2005EP1586326A1 Pharmaceutical compositions for treating neuronal damage and neurodegenerative diseases
10/19/2005EP1586319A1 Thiadiazolidinones as GSK-3 inhibitors
10/19/2005EP1586318A1 Thiadiazolidinones as GSK-3 inhibitors
10/19/2005EP1585762A1 Means for regulating the expression of human isoforms of ant
10/19/2005EP1585744A1 Process for making ondansetron and intermediates thereof
10/19/2005EP1585526A2 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same
10/19/2005EP1585525A1 Use of thiazolobenzoheterocycles for treating multiple sclerosis
10/19/2005EP1585522A2 Quinazolinones as potassium channel modulators
10/19/2005EP1585520A1 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/19/2005EP1585510A1 Alpha-aminoamide derivatives useful as antimigraine agents
10/19/2005EP1585481A2 Pyrazolopyrimidine compound and process for preparing the same
10/19/2005EP1487272B1 Choline-silicic acid complex with osmolytes and divalent trace elements
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1439830B1 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
10/19/2005EP1423117B1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
10/19/2005EP1414837B1 Adenosine a3 receptor agonists
10/19/2005EP1414446B1 Pramipexol as an anticonvulsive agent
10/19/2005EP1406902B1 Hexahydroazepino[4,5-g]indoles and indolines as 5-ht receptor ligands
10/19/2005EP1404656B9 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
10/19/2005EP1401837B1 Purine derivatives as a2b adenosine receptor antagonists
10/19/2005EP1397170B1 Safety shield system for prefilled syringes
10/19/2005EP1353948B1 Soluble cyclic analogues of the beta amyloide peptide
10/19/2005EP1345616A4 Reducing cellular damage in the human body
10/19/2005EP1337523B1 2,4-substituted pyridine derivatives
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1307245B1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter
10/19/2005EP1259251B1 Novel method for down-regulation of amyloid
10/19/2005EP1255740B1 Substituted arylpyrazines
10/19/2005EP1254131B1 Extraction of flavonoids
10/19/2005EP1240142B1 New modulators of dopamine neurotransmission
10/19/2005EP1237539B1 Oral solution containing galanthamine and a sweetening agent
10/19/2005EP1210344B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/19/2005EP1102752B1 Succinoylamino lactams as inhibitors of a beta protein production
10/19/2005EP1086071B1 Hyperforin derivatives, the use thereof and formulations containing them
10/19/2005EP1033998B1 Suppressing beta-amyloid-related changes in alzheimer's disease
10/19/2005CN1684965A Novel 1, 4-diazabicycloalkane derivatives, their preparation and use
10/19/2005CN1684962A Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684953A 吡唑化合物 Pyrazole compounds
10/19/2005CN1684708A Anti-NGF antibodies for the treatment of various disorders
10/19/2005CN1684705A Methods of use of compounds with preptin function
10/19/2005CN1684687A Modified release formulations of oxcarbazepine and derivatives thereof
10/19/2005CN1684681A Bicifadine formulation
10/19/2005CN1684677A Composition containing arachidonic acid or the combination of docosahexenoic acid therewith for enhancing cognitive abilities
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1684670A Methods and dosage forms for controlled delivery of paliperidone
10/19/2005CN1684594A Fruit and/or vegetable derived composition
10/19/2005CN1683408A Glucagon-like peptide analog, its composition and its using method
10/19/2005CN1683392A Chinese hard tick neuropeptide and its preparing method and use
10/19/2005CN1683365A Substituted dioxopentacyclic derivative and its use in preparing neuro regulator
10/19/2005CN1683340A 2-nitro-gen-dicyclic [2, 2, 1] hepta-5-ene-3-carboxylic derivative and its use preparing neuro regulator
10/19/2005CN1683004A Methods for treating pain
10/19/2005CN1682998A Medicine for treating paraplegia and its preparing method
10/19/2005CN1682989A Chinese medicine for treating depression
10/19/2005CN1682987A Process for preparing cell activation agent for treating motor nervous system disease
10/19/2005CN1682984A Shenerwuwei dripping pill for benefiting qi and nourishing yin and its preparing method
10/19/2005CN1682983A Medicinal composition containing wild jujube seed, lucid ganoderma and ginseng leaf and its preparing process and use
10/19/2005CN1682978A Compound ass-hide gelatin soft capsule and its preparing method
10/19/2005CN1682967A Fleabane oral disintegration tablet and its preparing process
10/19/2005CN1682956A Refining method for Liuweidihuang compound preparation by membrane technology separation
10/19/2005CN1682950A Composition containing nucleoside and its preparing method
10/19/2005CN1682946A Capsule for calming the wind and stopping twitching
10/19/2005CN1682927A Decumbent corydalis tuber freeze-dried powder injection and its preparing method
10/19/2005CN1682925A Acanthopanax bark-ginseng-Chinese angelica root-astragalus root dripping pill and its preparing method
10/19/2005CN1682924A Tortoise-astragalus root-ginseng dripping pill and its preparing method
10/19/2005CN1682922A Xinnaoshu dripping pill for invigorating qi and nourishing yin and its preparing method
10/19/2005CN1682920A Anshenning dripping pill for treating neurosism and its preparing method
1 ... 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 ... 1833